RxDoctor Payments DataLook up a doctor →

Mary D Amico, APRN

Adult Health · Danielson, CTNPI 1710312533

Payments from drug & device makers

$11,022in general payments, 2019–2025

Across 629 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • AstraZeneca$885
  • Lilly USA, LLC$766
  • Amgen$623
  • GSK$479
  • plus $5K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie124$1,803
Novo Nordisk68$1,101
AstraZeneca49$885
Lilly USA, LLC39$766
Amgen43$623
GSK27$479
Lundbeck LLC23$369
Sanofi-aventis U.S. LLC20$364
Boehringer Ingelheim15$344
Otsuka America Pharmaceutical, Inc.16$325
Vanda Pharmaceuticals Inc.13$275
Exact Sciences13$266
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)12$239
Johnson & Johnson13$229
Merck11$182
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$165
Idorsia Pharmaceuticals US Inc9$154
Pfizer10$151
E.r. Squibb & Sons, L.L.C.7$141
Biohaven Pharmaceutical Holding Company Ltd.8$139
Sunovion Pharmaceuticals Inc.8$129
Takeda Pharmaceuticals U.S.A., Inc.7$121
Astellas Pharma US Inc4$110
Eisai Inc.6$105
Kowa Pharmaceuticals America, Inc.7$104
Corcept Therapeutics4$103
Amarin Pharma, Inc.7$100
Teva Pharmaceuticals USA, Inc.4$96
Novartis4$95
Scilex Pharmaceuticals Inc.4$91
Bayer5$83
Sumitomo Pharma America, Inc.4$69
Resmed Corp1$66
Ardelyx, Inc.3$65
Neurocrine Biosciences, Inc.3$60
Almatica Pharma LLC2$53
Actelion Pharmaceuticals US, Inc.2$50
Soleno Therapeutics, Inc.2$44
Corium, LLC2$44
Cequr Corporation1$42
Bausch Health US, LLC2$41
Insightec,inc1$35
Evoke Pharma, Inc.2$32
Radius Health, Inc.2$32
Optinose US, Inc.1$29
Biohaven Pharmaceuticals, Inc.1$26
Indivior Inc.1$24
Antares Pharma, Inc.1$23
Collegium Pharmaceutical, Inc.1$23
Otsuka Pharmaceutical Development & Commercialization, Inc.1$19
Boston Scientific1$18
Adlon Therapeutics L.p.1$16
Inspire Medical Systems, Inc.1$16
Paratek Pharmaceuticals, Inc.1$16
Shield Therapeutics Inc1$15
Currax Pharmaceuticals LLC1$14
Mylan Specialty L.p.1$13

How this compares

$11,022 in reported general payments places this provider in the 95th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut

Medicare billing

Part B allowed, 2024
$29,370
Medicare patients
114
Services billed
390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Danielson

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →